Bolt Biotherapeutics (BOLT) Enterprise Value (2020 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Enterprise Value for 6 consecutive years, with -$11.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 48.99% to -$11.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.9 million through Dec 2025, down 48.99% year-over-year, with the annual reading at -$11.9 million for FY2025, 48.99% down from the prior year.
- Enterprise Value hit -$11.9 million in Q4 2025 for Bolt Biotherapeutics, up from -$39.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$8.0 million in Q4 2024 to a low of -$266.7 million in Q1 2021.
- Historically, Enterprise Value has averaged -$124.4 million across 5 years, with a median of -$122.8 million in 2023.
- Biggest five-year swings in Enterprise Value: plummeted 2196.1% in 2021 and later skyrocketed 92.18% in 2024.
- Year by year, Enterprise Value stood at -$186.2 million in 2021, then increased by 9.31% to -$168.9 million in 2022, then surged by 39.49% to -$102.2 million in 2023, then surged by 92.18% to -$8.0 million in 2024, then plummeted by 48.99% to -$11.9 million in 2025.
- Business Quant data shows Enterprise Value for BOLT at -$11.9 million in Q4 2025, -$39.6 million in Q3 2025, and -$73.7 million in Q2 2025.